Bristol-Myers Squibb (BMY) Misses Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $54.00 --0%
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
